UNSPSC 51162638: Narcotinum or noscapine

This classification denotes a tubulin binding agent and opioid receptor agonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8V32U4AOQU. European Medicines Agency schedules Noscapine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09383MIG. Noscapine generally arises in the molecular formula C22H23NO7.

The term NOSCAPINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 32, no 10 1978, list 18.) NOSCAPINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Narcotinum or noscapine bears US NLM identifiers UMLS ID C0028426 and NCI Concept Code C80589. SMILES: O1C(C2N(CCC3C2C(OC)C2OCOC2C3)C)C2C(C1=O)C(OC)C(OC)CC2.

UNSPSC 51162638 Narcotinum or noscapine is a Commodity code that covers pharmaceutical products, though recent state and local procurement activity under this code reflects broader pharmaceutical and drug-related supply categories rather than noscapine specifically. State and local governments are sourcing naloxone (an opioid antagonist used in overdose response), generic multi-source pharmaceuticals, and over-the-counter products through this code. Issuing bodies include county health departments, state procurement offices administering cooperative purchasing vehicles, and other state and local agencies. Seminole County, Florida has posted competitive solicitations for naloxone and drug deactivation systems, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, has issued an RFP to establish statewide pharmaceutical supply contracts covering multiple state and local government facilities across Minnesota and Oregon.

Activity concentrates in Florida and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the bid deadline was July 26, 2023. MMCAP issued RFP S1070000015802 on January 20, 2026, to establish multiple-award contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, with proposals due March 26, 2026, and awarded vendors to be provided to authorized wholesalers by May 15, 2026, with contract effectiveness July 1, 2026. Both opportunities require E-Verify compliance, comprehensive insurance coverage, and adherence to FDA or cGMP standards. The Seminole County procurement includes a two-year initial term with one-year renewal option; MMCAP contracts carry a two-year term for new respondents with optional extensions, and all products must maintain at least a six-month shelf life.